Immunoassay Market Worth $46.49 Billion by 2028

LONDON, Jan. 18, 2022 (GLOBE NEWSWIRE) – According to a new market research report Immunoassay market By product, solution (immunoassay kits {ELISA, Rapid Tests}, immunoassay platform, software and services), platform (chemiluminescence, radioimmunoassay), application (infectious diseases, oncology, allergy), end user – forecast to 2028 “, Published by Meticulous Research®, the immunoassay market is expected to grow at a CAGR of 7.5% from 2021 to reach US$46.49 billion by 2028.

Download a free report form now @

Immunoassays are biological analytical methods that use the specificity of the antigen-antibody reaction to detect and identify target molecules in biological samples. These methods are frequently used in clinical diagnosis, drug discovery, drug monitoring, and food testing. Immunoassays have played a vital role in pharmaceutical analysis, such as disease diagnosis, therapeutic drug surveillance, clinical pharmacokinetics, and bioequivalence studies in drug discovery and the pharmaceutical industries. The immunoassays industry is growing steadily due to various factors such as increasing research and diagnosis to test for infectious diseases with the development of new strains of pathogens every year. The market includes kits, reagents, systems or analyzers, software and services that can detect diseases or other conditions and can be used for research activities.

The Immunoassay market is primarily segmented by product, solutions, platform, application, end user, and geography. The study also assesses competitors in the industry and analyzes their market share on a global and regional level.

On the basis of product and solutions, the Immunoassay Kits & Reagents segment captured the largest share of the overall immunoassay market in 2021. The bulk of this segment is mainly attributable to the increase in the number of immunoassay tests being performed globally, resulting in repeat purchases of kits and reagents, increased focus on vaccine development to meet challenges such as antimicrobial resistance and epidemics, and technological advances in ELISpot test kits. Moreover, the increased demand for immunoassay-based COVID-19 test products along with the cost-effectiveness of these products is likely to expand the growth of the immunoassay kits and reagents segment in the coming years.

Talk to our analysts to understand the impact of COVID-19 on your business:

On the basis of the platform, the chemiluminescence immunoassay segment captured the largest share of the overall immunoassay market in 2021. Factors such as increased adoption of chemiluminescence assays in clinical diagnosis, research applications, and pharmaceutical analysis due to low cost per test, requirements of simple equipment, prompted sector growth.

Depending on the application, the infectious disease segment captured the largest share of the immunoassay market in 2021 due to recent regulatory approvals for infectious disease screening products, product launches, increased incidence of infectious diseases, and increased availability of COVID-19 test kits worldwide.

On the basis of the end user, the immunoassay market is broadly segmented into diagnostic reference laboratories, hospitals and clinics, research and academic laboratories, pharmaceutical and biotechnology companies, and other end users comprising of nursing homes, ambulatory care centers, blood banks and home health care agencies. In 2021, the diagnostic reference laboratories segment captured the largest share of the overall immunoassay market. High level of laboratory automation, high volume of patients resulting in an increase in the number of tests being performed in diagnostic laboratories, availability of well-equipped immunoassay systems and skilled labour, increasing prevalence of infectious diseases, and increased government initiatives. Factors that support the largest share of the end-user segment of diagnostic reference laboratories. However, the hospital and clinic sector is expected to grow faster during the forecast period due to more patients, more reimbursement for Medicare for clinical tests performed in hospitals, and improved healthcare infrastructure.

Quick Buy – Immunoassay Market Research Report:

On the basis of geography, the global immunoassays market is primarily divided into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share which can be attributed to the high prevalence of various infectious diseases, well-established healthcare sector, increased awareness regarding early disease diagnosis, increased penetration of advanced medical devices, and increased funding activities associated with the development of new assay solutions advanced immunology.

The report also includes an extensive evaluation of the product portfolio, geographical analysis, and key strategic developments adopted by the leading market participants in the industry over the past four years. The immunoassay market has witnessed a number of new product launches, approvals, agreements, collaborations, partnerships and expansions in recent years. For example, in April 2021, F. Hoffmann-La Roche AG (Switzerland) launched an Elecsys Anti-p53 immunoassay to detect anti-p53 antibodies in cancer patients. The test is used for patients with bowel cancer, esophageal cancer, and breast cancer. In September 2020, Siemens Healthineers AG (Germany) teamed up with Novartis Pharma AG (Switzerland), a pharmaceutical company, to support Novartis’ therapeutic pipeline by developing assays, primarily for the neural filament light chain (sNFL) immunofluorescence assay. Collaboration has also been made to support Novartis’ multiple sclerosis programs and other neuroscience programs.

The major players operating in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (US), Siemens AG (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), bioMérieux SA (France). ) and Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US) and Agilent Technologies, Inc. (US) and PerkinElmer, Inc. (USA) among others.

To get more market insights with a detailed table of content and numbers, click here:

Scope of the report:

Immunoassay Market, by Product and Solutions

  • Immunoassay kits and reagents
    • Elisa kits and reagents
    • Rapid Test Kits & Reagents
    • Western blot kits and reagents
    • ELISPOT kits and reagents
    • Other Immunoassay Kits and Reagents
  • Immunoassay Analyzers
  • Immunoassay programs and services

Other immunological kits and reagents consist of Resonance-based immunoassays, radioimmunoassays, microfluidic assays, nanomaterials and micromaterials-based assays.

Global Immunoassay Market, By Platform

  • Chemiluminescence for immunoassays
  • fluorescent immunoassays
  • colorimetric immunoassays
  • immune radio
  • Other immunoassay platforms

Other immunoassay platforms consist of turbidimetric immunoassays and counting immunoassays

Immunoassay market by application

  • Infectious diseases
  • Oncology
  • Endocrinology
  • cardiology
  • Bone and mineral diseases
  • autoimmune diseases
  • Other apps

Other applications consist of Toxicology, Hematology, Newborn Testing, Allergy and Astrology

Immunoassay market, by end users

  • Diagnostic Reference Laboratories
  • Hospitals and clinics
  • Research and academic laboratories
  • Pharma and biotechnology companies
  • Other users

Other end users consist of nursing homes, ambulatory care centers, blood banks and home health care agencies
Immunoassay market by geography

  • North America
  • Europe
    • Germany
    • United kingdom
    • France
    • Italia
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • Indonesia
    • Rest of Asia and the Pacific (Ruapak)
  • Latin america
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa

Download a free report form now @

In the midst of this crisis, careful research® It constantly assesses the impact of the COVID-19 pandemic on various sub-markets and enables global organizations to develop strategies for a post-COVID-19 world and to sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-

Related Reports:

In Vitro Diagnostics Market (IVD Market) by Product and Solutions (Consumables, Systems, Software and Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Laboratories) Diagnostics) – Forecasts to 2027

Lateral Flow Assays Market by Product (Collections, Readers), Technology (Sandwich, Competitive, Multiple), Application (Clinical) [Pregnancy, Infectious Diseases]food safety, drug development, veterinary medicine), end-user (hospital, home care) projections to 2027

influenza diagnostics market, by test type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]} , End User (Hospitals, Laboratories, Academics, Research Institutes) – Global Outlook to 2027

In Vitro Diagnostic Reagents (IVD) Market by Type (Antibodies, Oligonucleotides, DNA Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analytical Specific Reagent), End User (Manufacturer) IVD, Clinical Laboratory) – Global Outlook to 2027

About Meticulous Research®

Meticulous Research® was incorporated in 2010 and incorporated as Meticulous Market Research Pvt. In 2013 as a private limited company under the Companies Act 1956. Since its establishment, the company has become the leading provider of premium market information in North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

Our company name defines our services, strengths, and values. Right from the start, we have successfully researched, analyzed and presented critical market data with great attention to detail. Through meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation and analysis including both qualitative and quantitative research with the best team of analysts. We design rigorously analyzed, value-driven, intelligent syndicate market research reports, customized studies, rapid turnaround research, and consulting solutions to address business challenges for sustainable growth.

Mr. Khushal Bomb
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, United States
USA: +1-646-781-8004
Europe: +44-203-868-8738
Asia Pacific: +91744-7780008
email- [email protected]
Visit our website:
Connect with us on LinkedIn-
Content source:



Leave a Comment